We found a positive association between circulating chemerin levels and MetS prevalence, and a consistently negative correlation between chemerin and adiponectin levels, the latter of which is known for its protective role in diabetes, MetS, atherosclerosis, and various inflammatory processes [14]. The gene discussed is RARRES2; the disease is metabolic syndrome.